These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31002999)

  • 1. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
    Zhu H; Zhang Q; Chen G
    Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
    Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
    J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.
    Germanov E; Veinotte L; Cullen R; Chamberlain E; Butcher EC; Johnston B
    J Immunol; 2008 Jul; 181(1):81-91. PubMed ID: 18566372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
    Arrenberg P; Maricic I; Kumar V
    Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.
    Liggett JR; Kang J; Ranjit S; Rodriguez O; Loh K; Patil D; Cui Y; Duttargi A; Nguyen S; He B; Lee Y; Oza K; Frank BS; Kwon D; Li HH; Kallakury B; Libby A; Levi M; Robson SC; Fishbein TM; Cui W; Albanese C; Khan K; Kroemer A
    Front Immunol; 2022; 13():898799. PubMed ID: 36148239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT cells are important mediators of hepatic ischemia-reperfusion injury.
    Richards JA; Wigmore SJ; Anderton SM; Howie SEM
    Transpl Immunol; 2017 Dec; 45():15-21. PubMed ID: 28797737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
    Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
    Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
    Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
    Kato H; Kuriyama N; Duarte S; Clavien PA; Busuttil RW; Coito AJ
    J Hepatol; 2014 May; 60(5):1032-9. PubMed ID: 24412604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-aggressive CXCR6
    Dudek M; Pfister D; Donakonda S; Filpe P; Schneider A; Laschinger M; Hartmann D; Hüser N; Meiser P; Bayerl F; Inverso D; Wigger J; Sebode M; Öllinger R; Rad R; Hegenbarth S; Anton M; Guillot A; Bowman A; Heide D; Müller F; Ramadori P; Leone V; Garcia-Caceres C; Gruber T; Seifert G; Kabat AM; Mallm JP; Reider S; Effenberger M; Roth S; Billeter AT; Müller-Stich B; Pearce EJ; Koch-Nolte F; Käser R; Tilg H; Thimme R; Boettler T; Tacke F; Dufour JF; Haller D; Murray PJ; Heeren R; Zehn D; Böttcher JP; Heikenwälder M; Knolle PA
    Nature; 2021 Apr; 592(7854):444-449. PubMed ID: 33762736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF
    Yang F; Shang L; Wang S; Liu Y; Ren H; Zhu W; Shi X
    Oxid Med Cell Longev; 2019; 2019():2301903. PubMed ID: 31214277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers.
    Kang J; Liggett JR; Patil D; Ranjit S; Loh K; Duttargi A; Cui Y; Oza K; Frank BS; Kwon D; Kallakury B; Robson SC; Fishbein TM; Cui W; Khan K; Kroemer A
    Front Immunol; 2022; 13():899525. PubMed ID: 35833123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Wehr A; Baeck C; Ulmer F; Gassler N; Hittatiya K; Luedde T; Neumann UP; Trautwein C; Tacke F
    PLoS One; 2014; 9(11):e112327. PubMed ID: 25372401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
    Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
    J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity.
    Ke B; Shen XD; Tsuchihashi S; Gao F; Araujo JA; Busuttil RW; Ritter T; Kupiec-Weglinski JW
    Hum Gene Ther; 2007 Apr; 18(4):355-66. PubMed ID: 17439357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction.
    Chu MJ; Premkumar R; Hickey AJ; Jiang Y; Delahunt B; Phillips AR; Bartlett AS
    World J Gastroenterol; 2016 May; 22(19):4673-84. PubMed ID: 27217699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.
    Liss KHH; McCommis KS; Chambers KT; Pietka TA; Schweitzer GG; Park SL; Nalbantoglu I; Weinheimer CJ; Hall AM; Finck BN
    Liver Transpl; 2018 Jul; 24(7):908-921. PubMed ID: 29729104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury.
    Li L; Huang L; Sung SS; Lobo PI; Brown MG; Gregg RK; Engelhard VH; Okusa MD
    J Immunol; 2007 May; 178(9):5899-911. PubMed ID: 17442974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.